UK study finds mRNA COVID-19 vaccines provide biggest booster impact
The study found that six out of the seven boosters examined enhanced immunity after initial vaccination with Pfizer-BioNTech's…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Amgen announces positive top-line results from Otezla phase-III Discreet study in moderate-to-severe…
Otezla resulted in clinically and statistically significant improvements in measures of genital psoriasis at week 16 compared with…
Novavax says it could start making Omicron-specific vaccine in January
Other vaccine makers including Moderna and Pfizer have also begun working on Omicron-tailored COVID-19 shots
Biocon gets US FDA nod for generic product
The product is indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant and is available…
Moderna COVID vaccine highly effective five months after second dose: Study
Funded by Moderna, the study included 352,878 recipients of two doses of the vaccine matched to 352,878 unvaccinated individuals…
ZyCoV-D to be used in seven states initially
The seven states are Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar Pradesh and West Bengal
Thermo Fisher Scientific’s TaqPath COVID-19 Tests can detect the presence of the Omicron variant in…
MUMBAI, India – (December 02, 2021) – Thermo Fisher Scientific, the world leader in serving science confirmed that its TaqPath…
Antibody drug works against COVID-19 Omicron variant: GSK
In a statement, the British drugmaker said that lab tests and a study on hamsters have demonstrated the Sotrovimab antibody…
Serum Institute seeks DCGI’s approval for Covishield as booster dose
In an application to DCGI, Prakash Kumar Singh, Director, Government and Regulatory Affairs, SII, cited that the UK’s MHRA has…
Gilead and AWS collaborate on development and delivery of new medicines for patients
With AWS as its preferred cloud provider, Gilead uses AWS machine learning and analytics to better inform clinical trial design…